Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Gregory L. Weaver
Leeftijd : 64
Vermogen : 68 077 USD
Belangrijkste bedrijven : Atai Life Sciences N.V. - Atossa Therapeutics, Inc. - NOXXON Pharma N.V.
Overzicht 
Currently, Gregory L. Weaver is Chief Financial Officer at ATAI Life Sciences NV. Mr. Weaver is also on the board of Atossa Therapeutics, Inc. and NOXXON Pharma NV.

In his past career he held the position of Chief Financial Officer at Poniard Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President of Celsion Corp., Global Chief Financial Officer & Executive VP at Oryzon Genomics SA, Chief Financial & Accounting Officer at Eloxx Pharmaceuticals, Inc. and Chief Financial Officer for Sevion Therapeutics, Inc. (a subsidiary of Eloxx Pharmaceuticals, Inc.), Chief Financial Officer, Secretary & VP at MDRNA, Inc., Chief Financial Officer & Senior Vice President at Sirna Therapeutics, Inc., CFO, Secretary, Treasurer & Senior Vice President at Fibrocell Science, Inc., Chief Financial Officer for ILEX Oncology, Inc., Chief Financial Officer at Liminal BioSciences, Inc., Chief Financial Officer of Prism Technologies, Inc., Chief Financial Officer for Verity Solutions Group, Inc. and Chief Financial Officer for Oncology, Inc.

He received an MBA from Boston College and an undergraduate degree from Trinity University.


Posities en verantwoordelijkheden van Gregory L. Weaver 
NaamTitel Van
Atai Life Sciences N.V.
(Biotechnologie & Medisch Onderzoek)
Chief Financial Officer 2020
Atossa Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2013
NOXXON Pharma N.V.
(Biotechnologie & Medisch Onderzoek)
Member-Supervisory Board 2021


Belangnemingen van Gregory L. Weaver 
NaamAandelen%Totale waarde
Atai Life Sciences N.V. (ATAI)
(Biotechnologie & Medisch Onderzoek)
4 6660,0030%68 077 USD


Gregory L. WeaverPersoonlijk netwerk 
Meest gelezen nieuws 
24/11ELON MUSK : Musk verkoopt Tesla-aandelen ter waarde van $1,05 mrd, koopt 2,15 mln aandelen
MR
30/11JACK DORSEY : Jack Dorsey jaagt crypto, fintech droom post Twitter
MR
24/11JAMIE DIMON : Jamie Dimon grapt dat JPMorgan langer meegaat dan de communistische partij van China
MR
01/12JACK DORSEY : Dorsey-leiding Square verandert in Block met knipoog naar blockchain
MR
24/11ERIK NORDSTROM : Nordstrom-winst blijft achter bij ramingen door problemen met bevoorrading, aandelen kelderen
MR
29/11ANIL AMBANI : Indiase centrale bank start faillissementsprocedure tegen Reliance Capital; co moet voldoen
MR
03/12TILMAN FERTITTA : FAST Acquisition weigert fusie SPAC met Fertitta Entertainment te beëindigen
MR
23/11STUART ROSE : Morrisons aandeelhouders steunen CD&R's $10 mrd overname
MR
24/11ELON MUSK : Musk verkoopt weer aandelen Tesla
AM
03/12ELON MUSK : Elon Musk verkoopt nog meer aandelen Tesla
AM
Meer nieuws


© 2021 People and Ownership :   
Gregory L. Weaver Verbindingen